Table 1.
Tumor characteristics for Advanced Stage (IIIB-IIIC unresectable, IV).
| ADVANCED STAGE | |
|---|---|
| IIIB-IIIC (unresectable), IV N=787 | |
| Gender* | |
| Male | 476 (60) |
| Female | 307 (39) |
| missing | 4 (1) |
| Age | |
| ≤60 yrs | 355 (45) |
| >60 yrs | 432 (55) |
| BMI | |
| <25 | 315 (40) |
| ≥25 | 386 (49) |
| missing | 86 (11) |
| LDH | |
| Normal | 479 (61) |
| Abnormal | 43 (5) |
| Unknown | 265 (34) |
| Initial Stage | |
| In situ | 98 (12) |
| Stage I-II | 297 (38) |
| Stage III | 291 (37) |
| Stage IV | 101 (13) |
| BRAF executed | |
| No | 120 (15) |
| Yes | 594 (76) |
| Not applicable | 73 (9) |
| BRAF mutational status | |
| Mutant | 322 (54) |
| Wild Type | 269 (45.5) |
| unknown | 3 (0.5) |
| Mutant | |
| BRAF V600 | 56 (17.4) |
| BRAF V600E | 208 (64.6) |
| BRAF V600K | 34 (10.6) |
| Other | 24 (7.5) |
| Year BRAF executed | |
| <2013 | 498 (63) |
| ≥2013 | 289 (37) |
*4 patients did not report the gender.